首页 > 最新文献

Archives of hematology and blood diseases最新文献

英文 中文
The Role of Genetics Mutations in Genes APP, CST3, ITM2B in Inducate Hereditary Cerebral Amyloid Angiopathy Syndrome APP、CST3、ITM2B基因突变在诱导遗传性脑淀粉样血管病综合征中的作用
Pub Date : 2019-01-01 DOI: 10.22259/2639-3581.0201001
S. Asadi
HCAA syndrome is a genetic disorder that can lead to gradual loss of intellectual function (mental decline), stroke, and other neurological problems in the middle of adulthood. The mutation in the APP gene, located in the long arm of chromosome 21 as 21q21.3, is the most common genetic cause of HCAA syndrome.
HCAA综合征是一种遗传性疾病,可导致智力功能逐渐丧失(智力下降)、中风和其他神经系统问题。位于21号染色体长臂21q21.3的APP基因突变是HCAA综合征最常见的遗传原因。
{"title":"The Role of Genetics Mutations in Genes APP, CST3, ITM2B in Inducate Hereditary Cerebral Amyloid Angiopathy Syndrome","authors":"S. Asadi","doi":"10.22259/2639-3581.0201001","DOIUrl":"https://doi.org/10.22259/2639-3581.0201001","url":null,"abstract":"HCAA syndrome is a genetic disorder that can lead to gradual loss of intellectual function (mental decline), stroke, and other neurological problems in the middle of adulthood. The mutation in the APP gene, located in the long arm of chromosome 21 as 21q21.3, is the most common genetic cause of HCAA syndrome.","PeriodicalId":93414,"journal":{"name":"Archives of hematology and blood diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68287557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Experience with Reversal of Dabigatran with Two Doses of Idarucizumab, Hemodialysis, and Time in the Setting of Anuric Renal Failure and Major Gastrointestinal Bleeding 达比加群与两剂量依达鲁珠单抗、血液透析和时间在无尿肾衰和主要胃肠道出血患者中的逆转经验
Pub Date : 2018-01-01 DOI: 10.22259/2639-3581.0101004
P. Arpan, Cope Jessica, Harris Neil, Zumberg Marc
Dabigatran is a direct oral anticoagulant (DOAC) FDA approved for nonvalvular atrial fibrillation and venous thromboembolism. Benefits of dabigatran when compared to warfarin sodium include a shorter half-life and lack of need for routine monitoring. Recently idarucizumab was FDA approved for dabigatran reversal in the setting of life-threatening bleeding. Idarucizumab binds dabigatran neutralizing its activity. There is limited data regarding efficacy of redosing of idarucizumab as well as clearance of dabigatran in the setting of anuric renal failure. We present a case of a patient on chronic dabigatran for atrial fibrillation who was admitted for septic shock and developed gastrointestinal bleeding, anuric renal failure requiring dialysis for several days; despite two doses of idarucizumab and hemodialysis, the thrombin time remained elevated. Subsequently dabigatran levels returned and confirmed delayed clearance despite these interventions.
达比加群是FDA批准用于非瓣膜性房颤和静脉血栓栓塞的直接口服抗凝剂。与华法林钠相比,达比加群的好处包括半衰期更短,不需要常规监测。最近,idarucizumab被FDA批准用于达比加群逆转危及生命的出血。Idarucizumab结合达比加群,中和其活性。关于伊达鲁单抗再给药的疗效以及达比加群在无尿性肾衰竭的清除方面的数据有限。我们报告了一例慢性达比加群治疗心房颤动的患者,他因感染性休克入院,并发胃肠道出血,无尿肾衰竭,需要透析数天;尽管使用了两种剂量的依达鲁珠单抗和血液透析,凝血酶时间仍然升高。随后达比加群水平恢复,尽管有这些干预措施,但证实清除延迟。
{"title":"An Experience with Reversal of Dabigatran with Two Doses of Idarucizumab, Hemodialysis, and Time in the Setting of Anuric Renal Failure and Major Gastrointestinal Bleeding","authors":"P. Arpan, Cope Jessica, Harris Neil, Zumberg Marc","doi":"10.22259/2639-3581.0101004","DOIUrl":"https://doi.org/10.22259/2639-3581.0101004","url":null,"abstract":"Dabigatran is a direct oral anticoagulant (DOAC) FDA approved for nonvalvular atrial fibrillation and venous thromboembolism. Benefits of dabigatran when compared to warfarin sodium include a shorter half-life and lack of need for routine monitoring. Recently idarucizumab was FDA approved for dabigatran reversal in the setting of life-threatening bleeding. Idarucizumab binds dabigatran neutralizing its activity. There is limited data regarding efficacy of redosing of idarucizumab as well as clearance of dabigatran in the setting of anuric renal failure. We present a case of a patient on chronic dabigatran for atrial fibrillation who was admitted for septic shock and developed gastrointestinal bleeding, anuric renal failure requiring dialysis for several days; despite two doses of idarucizumab and hemodialysis, the thrombin time remained elevated. Subsequently dabigatran levels returned and confirmed delayed clearance despite these interventions.","PeriodicalId":93414,"journal":{"name":"Archives of hematology and blood diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68287282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heparin-Induced Thrombocytopenia after Severe Injury in an Aged Woman: Using Clinical Scoring System 老年妇女严重损伤后肝素诱导的血小板减少:使用临床评分系统
Pub Date : 2018-01-01 DOI: 10.22259/2639-3581.0101003
Y. Shimazu, M. Toyofuku, M. Masuda, Maiko Inada, M. Nohgawa
{"title":"Heparin-Induced Thrombocytopenia after Severe Injury in an Aged Woman: Using Clinical Scoring System","authors":"Y. Shimazu, M. Toyofuku, M. Masuda, Maiko Inada, M. Nohgawa","doi":"10.22259/2639-3581.0101003","DOIUrl":"https://doi.org/10.22259/2639-3581.0101003","url":null,"abstract":"","PeriodicalId":93414,"journal":{"name":"Archives of hematology and blood diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68287274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of Prognostic Significance of Monosomy 7 in Myeloid Malignancies Sole or with Recurrent Chromosomal Abnormalities: An Indian Experience 单体7在单纯髓系恶性肿瘤或伴复发性染色体异常的预后意义评估:印度经验
Pub Date : 2018-01-01 DOI: 10.22259/2639-3581.0102002
P. Trivedi, Dharmesh M. Patel, Priya K. Varma, Dhara C. Ladani, Darshita H. Patel, M. Kazi, P. Patel
{"title":"Assessment of Prognostic Significance of Monosomy 7 in Myeloid Malignancies Sole or with Recurrent Chromosomal Abnormalities: An Indian Experience","authors":"P. Trivedi, Dharmesh M. Patel, Priya K. Varma, Dhara C. Ladani, Darshita H. Patel, M. Kazi, P. Patel","doi":"10.22259/2639-3581.0102002","DOIUrl":"https://doi.org/10.22259/2639-3581.0102002","url":null,"abstract":"","PeriodicalId":93414,"journal":{"name":"Archives of hematology and blood diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68287433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalance of Blood Sugar among Patients Attending Eye Clinic in Guinness Eye Hospital Onitsha -2010 to 2017 2010 - 2017年健力士眼科医院眼科门诊患者血糖患病率调查
Pub Date : 2018-01-01 DOI: 10.22259/2639-3581.0101006
Onwurah Ow, Okoye Je, Ikegbue Hc, Nwagu Cl, Onyemelue Om, Apakama Ai, Alozie Iu
{"title":"Prevalance of Blood Sugar among Patients Attending Eye Clinic in Guinness Eye Hospital Onitsha -2010 to 2017","authors":"Onwurah Ow, Okoye Je, Ikegbue Hc, Nwagu Cl, Onyemelue Om, Apakama Ai, Alozie Iu","doi":"10.22259/2639-3581.0101006","DOIUrl":"https://doi.org/10.22259/2639-3581.0101006","url":null,"abstract":"","PeriodicalId":93414,"journal":{"name":"Archives of hematology and blood diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68287304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Promoting Public Health Campaign on Awareness and Screening for Multiple Myeloma in Nigeria 促进公众健康运动,提高对尼日利亚多发性骨髓瘤的认识和筛查
Pub Date : 2018-01-01 DOI: 10.22259/2639-3581.0102003
Ogbonna Collins Nwabuko, E. Igbigbi, Oseikhuemen Adeboye Ejele
{"title":"Promoting Public Health Campaign on Awareness and Screening for Multiple Myeloma in Nigeria","authors":"Ogbonna Collins Nwabuko, E. Igbigbi, Oseikhuemen Adeboye Ejele","doi":"10.22259/2639-3581.0102003","DOIUrl":"https://doi.org/10.22259/2639-3581.0102003","url":null,"abstract":"","PeriodicalId":93414,"journal":{"name":"Archives of hematology and blood diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68287492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
A Model of Primary and Secondary Preventions of Lymphedema of Superficial Lymphatic System Using Warm Running Water and Massage 温开水加按摩预防浅表淋巴系统淋巴水肿的一级和二级模型
Pub Date : 2018-01-01 DOI: 10.22259/2639-3581.0102005
K. Cheng
{"title":"A Model of Primary and Secondary Preventions of Lymphedema of Superficial Lymphatic System Using Warm Running Water and Massage","authors":"K. Cheng","doi":"10.22259/2639-3581.0102005","DOIUrl":"https://doi.org/10.22259/2639-3581.0102005","url":null,"abstract":"","PeriodicalId":93414,"journal":{"name":"Archives of hematology and blood diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68287542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Extramedullary Myeloidsarcoma in Children Presenting with Pancreatic Tumor 以胰腺肿瘤为表现的儿童髓外骨髓肉瘤
Pub Date : 2018-01-01 DOI: 10.22259/2639-3581.0102001
Pham Thi Viet Huong, Trinh Hong Son
Background: Myeloidsarcoma (MS) is a tumor composed of granulocytic precursor cells occurring in an extramedullary location.MS are rare neoplasms whose knowledge is largely based on case reports. MS is often initially misdiagnosed, the most common alternative diagnoses being lymphoma, undifferentiated cancer, malignant melanoma, extramedullary hematopoiesis and inflammation. Immunohistochemistry and immunophenotying are crucial for the accurate diagnosis of MS. Aim: The aim of this study is to introduce a boy with a very rare clinical case of MS in the diagnosis of myelodysplastic syndrome. Case report: A 9-year-old boy with extramedullary MS has been treated in Pediatric Oncology Department, K hospital from May, 2016 to August, 2016. Method: Retrospectively describe a clinical case. Result: The patient is described smilar to some other cases in literature. He was treated with an Acute Myeloicytic Leukemia conventional chemotherapeutic protocol and discharged. Conclusion: The case is rare in clinical practice. The exact diagnosis was made by immunohistochemistry and immunophenotying. Treatment with systemic chemotherapy was associated with his primary favorable survival outcome.
背景:髓样肉瘤(MS)是一种发生在髓外部位的由粒细胞前体细胞组成的肿瘤。多发性硬化症是一种罕见的肿瘤,其知识主要基于病例报告。MS最初常常被误诊,最常见的替代诊断是淋巴瘤、未分化癌、恶性黑色素瘤、髓外造血和炎症。免疫组织化学和免疫表型对MS的准确诊断至关重要目的:本研究的目的是介绍一个非常罕见的MS临床病例的男孩在骨髓增生异常综合征的诊断中。病例报告:一名9岁男童于2016年5月至2016年8月在K医院儿科肿瘤科治疗髓外MS。方法:回顾性描述1例临床病例。结果:本病例描述与文献中其他病例相似。患者接受急性髓细胞性白血病常规化疗方案治疗后出院。结论:本病例临床罕见。通过免疫组织化学和免疫表型检查进行准确诊断。全身化疗治疗与他的主要有利生存预后相关。
{"title":"Extramedullary Myeloidsarcoma in Children Presenting with Pancreatic Tumor","authors":"Pham Thi Viet Huong, Trinh Hong Son","doi":"10.22259/2639-3581.0102001","DOIUrl":"https://doi.org/10.22259/2639-3581.0102001","url":null,"abstract":"Background: Myeloidsarcoma (MS) is a tumor composed of granulocytic precursor cells occurring in an extramedullary location.MS are rare neoplasms whose knowledge is largely based on case reports. MS is often initially misdiagnosed, the most common alternative diagnoses being lymphoma, undifferentiated cancer, malignant melanoma, extramedullary hematopoiesis and inflammation. Immunohistochemistry and immunophenotying are crucial for the accurate diagnosis of MS. Aim: The aim of this study is to introduce a boy with a very rare clinical case of MS in the diagnosis of myelodysplastic syndrome. Case report: A 9-year-old boy with extramedullary MS has been treated in Pediatric Oncology Department, K hospital from May, 2016 to August, 2016. Method: Retrospectively describe a clinical case. Result: The patient is described smilar to some other cases in literature. He was treated with an Acute Myeloicytic Leukemia conventional chemotherapeutic protocol and discharged. Conclusion: The case is rare in clinical practice. The exact diagnosis was made by immunohistochemistry and immunophenotying. Treatment with systemic chemotherapy was associated with his primary favorable survival outcome.","PeriodicalId":93414,"journal":{"name":"Archives of hematology and blood diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68287353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Agressive Acute Myeloid Leukemia with inv(3)(q21q26.2): A Case Report 侵袭性急性髓系白血病伴inv(3)(q21q26.2) 1例报告
Pub Date : 2018-01-01 DOI: 10.22259/2639-3581.0101001
Í. M. Santos-Pirath, Chandra Chiappin Cardoso, Camila Matiollo, M. Auat, F. Maraslis, S. Maluf, Maria Cláudia Santos da Silva
{"title":"Agressive Acute Myeloid Leukemia with inv(3)(q21q26.2): A Case Report","authors":"Í. M. Santos-Pirath, Chandra Chiappin Cardoso, Camila Matiollo, M. Auat, F. Maraslis, S. Maluf, Maria Cláudia Santos da Silva","doi":"10.22259/2639-3581.0101001","DOIUrl":"https://doi.org/10.22259/2639-3581.0101001","url":null,"abstract":"","PeriodicalId":93414,"journal":{"name":"Archives of hematology and blood diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68287226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary Pulmonary Lymphoma Presenting as the Lung Abscess: A Case Report 原发性肺淋巴瘤表现为肺脓肿1例
Pub Date : 2018-01-01 DOI: 10.22259/2639-3581.0102004
W. Insiripong, S. Insiripong
{"title":"Primary Pulmonary Lymphoma Presenting as the Lung Abscess: A Case Report","authors":"W. Insiripong, S. Insiripong","doi":"10.22259/2639-3581.0102004","DOIUrl":"https://doi.org/10.22259/2639-3581.0102004","url":null,"abstract":"","PeriodicalId":93414,"journal":{"name":"Archives of hematology and blood diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68287507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
期刊
Archives of hematology and blood diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1